JAMIE BAAB: Open Payments
NPI 1811514094 · ABERDEEN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,304 in 65 payments from 12 companies in 2025. Trend: 2023 $1,975 · 2024 $1,740 · 2025 $1,304
Food & beverage: $1,304
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $238 |
| Amgen Inc. | 15 | $189 |
| PFIZER INC. | 10 | $162 |
| AstraZeneca Pharmaceuticals LP | 8 | $158 |
| Lilly USA, LLC | 7 | $137 |
| ABBVIE INC. | 5 | $109 |
| GlaxoSmithKline, LLC. | 5 | $99 |
| INTUITIVE SURGICAL, INC. | 1 | $77 |
| Exact Sciences Corporation | 3 | $67 |
| Dexcom, Inc. | 1 | $26 |
Products named: MOUNJARO, FARXIGA, NURTEC ODT, OTEZLA, TRELEGY ELLIPTA, Wegovy, Da Vinci Surgical System, Ozempic.
Industry payments across MD — which companies pay providers there.
